Most azole antifungal resistance mutations in the drug target provide cross-resistance and carry no intrinsic fitness cost

Camille Bédard(Université Laval), Christian R. Landry(PROTEO), Jonathan Boisvert(Institut national de recherche en sciences et technologies du numérique), Anna Fijarczyk(PROTEO), Jehoshua Sharma(University of Guelph), Alexandre K. Dubé(PROTEO), Isabelle Gagnon‐Arsenault(PROTEO), Laetitia Maroc(University of Guelph), Samuel Plante(Université de Sherbrooke), Rebecca S. Shapiro(University of Guelph), Alicia Pageau(PROTEO)
bioRxiv (Cold Spring Harbor Laboratory)
December 14, 2023
Cited by 6


Related Papers